213 results on '"Herrera, Vivian"'
Search Results
2. Effects of probiotics on markers of immunity and inflammation in the elderly
3. Incidence rates of comorbidities among patients with psoriasis in the United States
4. Improving Quality of Acute Asthma Care in US Hospitals Changes Between 1999-2000 and 2012-2013
5. Real-world durability of relapse rate reduction in patients with multiple sclerosis receiving fingolimod for up to 3 years: a retrospective US claims database analysis
6. Influence of delayed sample processing on blood immune cell phenotypes, immune cell responses and serum anti-influenza vaccine antibody titres
7. Real-world persistence with fingolimod for the treatment of multiple sclerosis: A systematic review and meta-analysis
8. Burden and treatment patterns of advanced basal cell carcinoma among commercially insured patients in a United States database from 2010 to 2014
9. Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA
10. Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort study
11. Improving Quality of Acute Asthma Care in US Hospitals: Changes Between 1999-2000 and 2012-2013
12. Children and Adults With Frequent Hospitalizations for Asthma Exacerbation, 2012-2013: A Multicenter Observational Study
13. Underuse of guideline-recommended long-term asthma management in children hospitalized to the intensive care unit: a multicenter observational study
14. Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control
15. Relationship between vitamin intake and total antioxidant capacity in elderly adults /Relacion entre ingesta de vitaminas y capacidad atnioxidante total en adultos mayores/ Relacao entre a ingestao de vitaminas e a capacidade antioxidante total em idosos
16. Interaction of Therapeutic d-Peptides with Aβ42 Monomers, Thermodynamics, and Binding Analysis
17. Association of Guideline-concordant Acute Asthma Care in the Emergency Department With Shorter Hospital Length of Stay: A Multicenter Observational Study
18. Relationship between age, frailty, length of care home residence and biomarkers of immunity and inflammation in older care residents in the UK
19. Probiotics to reduce antibiotic administration in care home residents aged 65 years and older: the PRINCESS RCT
20. Relationships Between Age, Frailty, Length of Care Home Residence and Biomarkers of Immunity and Inflammation in Older Care Home Residents in the United Kingdom
21. Combination of the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis, BB-12 Has Limited Effect on Biomarkers of Immunity and Inflammation in Older People Resident in Care Homes: Results From the Probiotics to Reduce Infections iN CarE home reSidentS Randomized, Controlled Trial
22. Determination of Pericardial Adipose Tissue Increases the Prognostic Accuracy of Coronary Artery Calcification for Future Cardiovascular Events
23. Out-of-Pocket Drug Costs and Drug Utilization Patterns of Postmenopausal Medicare Beneficiaries with Osteoporosis
24. In Vitro Effects of Live and Heat-Inactivated Bifidobacterium animalis Subsp. Lactis, BB-12 and Lactobacillus rhamnosus GG on Caco-2 Cells
25. Characterization of insufficient responders to ustekinumab in patients with moderate-to-severe psoriasis in the US Corrona Psoriasis Registry.
26. Characterization of insufficient responders to ustekinumab in patients with moderate-to-severe psoriasis in the US Corrona Psoriasis Registry
27. Time to treatment failure following initiation of fingolimod versus teriflunomide for multiple sclerosis: a retrospective US claims study
28. Characterization of insufficient responders to anti-tumor necrosis factor therapies in patients with moderate to severe psoriasis: real-world data from the US Corrona Psoriasis Registry
29. TREATMENT OF LUPIC NEPHRITIS: RESULT OF 5 YEARS EXPERIENCE IN A SCHOOL HOSPITAL
30. Abstract 4166: Hereditary cancer syndromes in Guatemalan population
31. The Impact of Price Reductions After Loss of Exclusivity in a Cost-Effectiveness Analysis: Fingolimod Versus Interferon Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
32. Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry
33. Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
34. Characterization of insufficient responders to anti-tumor necrosis factor therapies in patients with moderate to severe psoriasis: real-world data from the US Corrona Psoriasis Registry.
35. Exploration of the Product of the 5-Point Investigator’s Global Assessment and Body Surface Area (IGA × BSA) as a Practical Minimal Disease Activity Goal in Patients with Moderate-to-Severe Psoriasis
36. Associations Between Treatment Satisfaction, Medication Beliefs, and Adherence to Disease-Modifying Therapies in Patients with Multiple Sclerosis
37. Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR Study
38. Time to treatment failure following initiation of fingolimod versus teriflunomide for the treatment of multiple sclerosis: a retrospective U.S. claims study (P1.372)
39. Impact of Multiple Sclerosis Relapse Severity on Health Care Costs (P4.375)
40. Formulation and creation of a supplier base according to the PMI methodology
41. Relação entre a ingestão de vitaminas e a capacidade antioxidante total em idosos
42. Clinical Characteristics, Disease Activity, and Patient‐Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
43. Adherence, persistence, and discontinuation among Hispanic and African American patients with multiple sclerosis treated with fingolimod or glatiramer acetate
44. Treatment Changes in Patients With Moderate to Severe Psoriasis: A Retrospective Chart Review
45. Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis
46. Real-World Adherence and Persistence to Oral Disease-Modifying Therapies in Multiple Sclerosis Patients Over 1 Year
47. Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry
48. Economic Impact of Above-Label Dosing with Etanercept, Adalimumab, or Ustekinumab in Patients with Psoriasis
49. Does opening access to oral disease modifying therapy increase rates of initiation and reduce disease-related medical costs in a national population of patients with multiple sclerosis? (P3.403)
50. Real-World Treatment Persistence Among Multiple Sclerosis Patients on Injectable Disease Modifying Therapies (P2.405)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.